Clentiazem

This classification denotes a calcium channel blocker with the molecular formula C22H25CLN2O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, 40DK034DRC chemically known as 1,5-benzothiazepin-4(5h)-one, 3-(acetyloxy)-8-chloro-5-(2-(dimethylamino)ethyl)-2,3-dihydro-2-(4-methoxyphenyl)-, (2s-cis)- but generally known as clentiazem, which bears US NIH Compound Identifier 57026. European Medicines Agency schedules Clentiazem in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06653MIG. The term CLENTIAZEM is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 4, no. 3 1990, list 30). Most nations schedule clentiazem under HS 29349990 and SITC 51579. As of Q4 2014, CLENTIAZEM remains the US FDA Preferred Term for this commodity. Clentiazem bears US NLM identifiers UMLS ID C0075753 and NCI Concept Code C81679. SMILES: CC(=O)OC1C(SC2=C(C=CC(=C2)CL)N(C1=O)CCN(C)C)C3=CC=C(C=C3)OC.